NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.33
Delayed Data
As of Apr 20
 -0.016 / -0.48%
Today’s Change
2.25
Today|||52-Week Range
5.00
-13.40%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +79.96% increase from the last price of 3.33.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$5.6M
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -533.34%
 
 
 
 
 
 
Growthannually 75.52%
 
 
 
 
 
 

Sales

Growthquarterly -12.13%
 
 
 
 
 
 
Growthannually 26.97%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.